Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023

March 18, 2024

https://www.globenewswire.com/news-release/2024/03/18/2848106/0/en/Daxor-Corporation-Reports-Increase-in-NAV-to-7-08-Per-Share-and-31-8-Percent-Increase-in-Unaudited-Revenue-of-Operating-Division-for-the-Year-Ended-December-31-2023.html

Strong Start to 2024 with Unaudited Revenue Climbing 229.1% in First Two Months of 2024 YoY

Oak Ridge, TN, March 18, 2024 (GLOBE NEWSWIRE) — Daxor Corporation (Nasdaq:DXR), the global leader in blood volume measurement technology, announces today the filing of its Annual Report to Shareholders on Form N-CSR, disclosing its schedule of portfolio holdings as of December 31, 2023.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.